The effects of atorvastatin on arterial stiffness in male patients with type 2 diabetes

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Davenport, Colin ^a   Ashley, David T ^b   O'Sullivan, Eoin P ^a   McHenry, Claire M ^a   Agha, Amar ^a   Thompson, Christopher J ^a   O'Gorman, Donal J ^b   Smith, Diarmuid ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOPROTEGERIN; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTERIAL STIFFNESS; ARTICLE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; DIABETIC PATIENT; DYSLIPIDEMIA; FEMORAL ARTERY; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE WAVE; SMOKING; TREATMENT DURATION; VASCULITIS; ADULT; AGED; BLOOD; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATORVASTATIN CALCIUM; BIOMARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PULSE WAVE ANALYSIS; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84929318577     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/846807     Document Type: Article

References (19)

1. S. M. Grundy, I. J. Benjamin, G. L. Burke et al., "Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association", Circulation, vol. 100, no. 10, pp. 1134-1146, 1999.
2. D. Agnoletti, A. Lieber, Y. Zhang et al., "Central hemodynamic modifications in diabetes mellitus", Atherosclerosis, vol. 230, no. 2, pp. 315-321, 2013.
3. M. Cecelja and P. Chowienczyk, "Role of arterial stiffness in cardiovascular disease", JRSM Cardiovascular Disease, vol. 1, no. 4, p. 11, 2012.
4. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis, "Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis", Journal of the American College of Cardiology, vol. 55, no. 13, pp. 1318-1327, 2010.
5. J. Steppan, V. Barodka, D. E. Berkowitz, and D. Nyhan, "Vascular stiffness and increased pulse pressure in the aging cardiovascular system", Cardiology Research and Practice, vol. 2011, Article ID 263585, 11 pages, 2011.
6. K. K. Koh, "Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability", Cardiovascular Research, vol. 47, no. 4, pp. 648-657, 2000.
7. J. S. Orr, A. L. Dengo, J. M. Rivero, and K. P. Davy, "Arterial destiffening with atorvastatin in overweight and obese middleaged and older adults", Hypertension, vol. 54, no. 4, pp. 763-768, 2009.
8. A. I. Kanaki, P. A. Sarafidis, P. I. Georgianos et al., "Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia", The American Journal of Hypertension, vol. 26, no. 5, pp. 608-616, 2013.
9. E. C. Rizos, A. P. Agouridis, and M. S. Elisaf, "The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review", Current Vascular Pharmacology, vol. 8, no. 5, pp. 638-644, 2010.
10. A. Van Campenhout and J. Golledge, "Osteoprotegerin, vascular calcification and atherosclerosis", Atherosclerosis, vol. 204, no. 2, pp. 321-329, 2009.
11. J. D. Fontes, J. F. Yamamoto, M. G. Larson et al., "Clinical correlates of change in inflammatory biomarkers: the Framingham Heart Study", Atherosclerosis, vol. 228, no. 1, pp. 217-223, 2013.
12. T. Coutinho, B. A. Borlaug, P. A. Pellikka, S. T. Turner, and I. J. Kullo, "Sex differences in arterial stiffness and ventriculararterial interactions", Journal of the American College of Cardiology, vol. 61, no. 1, pp. 96-103, 2013.
13. A. Lipton, S. M. Ali, K. Leitzel et al., "Serum osteoprotegerin levels in healthy controls and cancer patients", Clinical Cancer Research, vol. 8, no. 7, pp. 2306-2310, 2002.
14. S. F. Dinneen and H. C. Gerstein, "The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature", Archives of Internal Medicine, vol. 157, no. 13, pp. 1413-1418, 1997.
15. http://www.medicines.ie/medicine/7551/SPC/Lipitor+10+mg+film-coated+tablets/.
16. S. Laurent, J. Cockcroft, L. van Bortel et al., "Expert consensus document on arterial stiffness: methodological issues and clinical applications", European Heart Journal, vol. 27, no. 21, pp. 2588-2605, 2006.
17. S. Mukherjee, P. Mukhopadhyay, K. Pandit, and S. Chowdhury, "Atorvastatin improves arterial stiffness in normotensive normolipidaemic persons with type 2 diabetes", Journal of the Indian Medical Association, vol. 106, no. 11, pp. 716-719, 2008.
18. K. Shinohara, T. Shoji, E. Kimoto et al., "Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus", Journal of Atherosclerosis and Thrombosis, vol. 12, no. 4, pp. 205-210, 2005.
19. N. B. Johansen, M. Charles, D. Vistisen et al., "Effect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study", Diabetes Care, vol. 35, no. 11, pp. 2207-2214, 2012.